Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence
10.1080/14740338.2020.1776699
Saved in:
Main Authors: | Nelson Rodrigues, Roger McIntyre, Orly Lipsitz, Yena Lee, Danielle S. Cha, Flora Nasri, Hartej Gill, Leanna Lui, Mehala Subramaniapillai, Kevin Kratiuk, Kangguang Lin, Roger Ho, Rodrigo Mansur, Joshua Rosenblat |
---|---|
Other Authors: | DEPT OF PSYCHOLOGICAL MEDICINE |
Format: | Article |
Published: |
Taylor & Francis
2020
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/176316 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Suicide reduction in Canada during the COVID-19 pandemic: lessons informing national prevention strategies for suicide reduction
by: McIntyre, Roger S., et al.
Published: (2022) -
A Review of Potential Neuropathological Changes Associated with Ketamine
by: Danica Nogo, et al.
Published: (2022) -
Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review
by: Alnefeesi, Yazen, et al.
Published: (2022) -
Registered Clinical Trials Investigating Treatment of Long COVID: A Scoping Review and Recommendations for Research
by: Felicia Ceban, et al.
Published: (2022) -
Drug-Drug Interactions as a Result of Co-Administering ?9-THC and CBD with Other Psychotropic Agents
by: Carola Rong, et al.
Published: (2018)